I agree that should be the case Hank, but the shorts have managed to take us down after the regulatory filing was made, I think it's impossible to ignore how well they've managed to manipulate the stock to date. I'm still of the belief that by mid-April we could have an approval. I don't know that the bashers won't keep us roughly where we are right up to the time we get the announcement.
If on the other hand we do get down to day 150, I suspect they won't be able to keep us below the $.75 to $1 range, but I'll admit being surprised by them many times before.
Something that none of us have mentioned in awhile is the peer reviewed article in Nature. I suppose if that comes out before approval it could spur higher prices even sooner.
I certainly don't know when, but one morning soon I expect to wake up and find I'm either already a lot wealthier, or will be shortly as the trading's been halted on news of the approval. Some of you will know it's coming before the market opens, but I'm rarely up at the open, and often not until the first hour or two of trading. If trading is halted, I suspect it will resume in an hour or so, at the longest, but as news grows I believe the price will grow from wherever they open trading.
As the shorts have to cover in the next few days I think we'll go higher, but eventually we'll retrench a bit then on to new highs.
Gary
AI
Market Data 
Markets 
